A peptide is a short chain of amino acids. Long enough to fold into a shape a receptor recognises; short enough that it is synthesised rather than harvested. Everything else follows from those two facts.
Where the line sits
There is no hard boundary between a peptide and a protein — the convention is roughly fifty amino acids. Below that, a molecule can be built to order on a synthesiser, and its sequence can be verified afterwards against a theoretical mass. Above it, you are in the business of expressing and purifying a protein, which is a different industry with different costs.
That is why the compounds in this category are peptides and not proteins. It is a manufacturing boundary as much as a biological one.
The shape is the mechanism
A peptide does not supply energy and it is not building material. It folds into a shape that fits a receptor, and the receptor does the rest — the cell was already capable of the response before the peptide arrived.
That is worth restating, because it is the part most marketing copy quietly inverts. The peptide does not do the thing. It asks for the thing.
Why precision beats volume
Once you accept that a peptide is an instruction, the dosing follows. Doubling an instruction does not make it clearer; it makes the receiver stop listening. The useful range is narrow and the cost of overshooting it is a blunted response, not a stronger one.
Which is why a supplier's milligram count is a much less interesting number than its purity method — and why the vial you want is the one whose certificate you have read.
